ArticleNeuro-oncology2024

Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment.

Denise Obrecht-Sturm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.